Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
0.610
-0.005 (-0.78%)
Feb 21, 2025, 4:00 PM EST - Market closed
Generation Bio Co. Market Cap
Generation Bio Co. has a market cap or net worth of $40.76 million as of February 21, 2025. Its market cap has decreased by -68.37% in one year.
Market Cap
40.76M
Enterprise Value
-65.28M
1-Year Change
-68.37%
Ranking
Category
Stock Price
$0.61
Market Cap Chart
Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.07B to $40.76M, a decrease of -96.20%. That is a compound annual growth rate of -50.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 40.76M | -42.43% |
| Dec 31, 2024 | 70.80M | -35.06% |
| Dec 29, 2023 | 109.03M | -53.31% |
| Dec 30, 2022 | 233.53M | -41.89% |
| Dec 31, 2021 | 401.89M | -68.88% |
| Dec 31, 2020 | 1.29B | 20.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |